# Trial of Second Generation Designer T Cells in Colorectal Carcinoma

> **NCT00673322** · PHASE1 · TERMINATED · sponsor: **Roger Williams Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Gene Modified T Cells

## Key facts

- **NCT ID:** NCT00673322
- **Lead sponsor:** Roger Williams Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** This study will be incorporated into another study.
- **Last updated:** 2016-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673322, "Trial of Second Generation Designer T Cells in Colorectal Carcinoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00673322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*